A case in Taiwan highlights the dangers of relying solely on ‘natural’ remedies like bitter gourd juice for blood sugar management in people with kidney impairment, underscoring the importance of medical treatment and dietary caution. A nephrologist in Taiwan is…
Emerging research suggests that personalised nutrition strategies could enhance the success of GLP-1-based weight-loss treatments like Wegovy and Ozempic, particularly for patients who struggle with side effects or inadequate response. Experts advocate for integrating biological, genetic, and dietary insights to…
Originally developed to manage Type 2 diabetes, GLP-1 drugs like Ozempic and Wegovy are now being recognised for their broader health benefits and potential risks as they become more widely used beyond weight loss. GLP-1 medications, best known by brand…
While plant-based meats may have limited impact on blood sugar, their health benefits depend heavily on ingredients and processing. Experts advise moderation and mindful pairing to fit diabetes-friendly diets. Plant-based meats may have little direct effect on blood sugar, but…
A surge in marketing claims suggesting cinnamon as a cure for diabetes is challenged by health authorities, emphasising that evidence remains inconclusive and unproven supplements may be unsafe. The latest wave of diabetes-supplement marketing leans on a simple, comforting idea:…
Experts warn that while GLP-1 medicines like semaglutide and tirzepatide are revolutionising type 2 diabetes care, patients must pay close attention to hydration, nutrition, and exercise to optimise results and avoid risks such as dehydration and nutrient deficiencies. GLP-1 medicines…
While sourdough bread, especially made with whole grains, may cause a slower rise in blood sugar compared to white bread, it still affects glucose levels, emphasising portion control and balanced meals for diabetics. Sourdough bread can still raise blood sugar,…
Research using Veterans Health Administration data reveals that adding GLP-1 receptor agonists to basal insulin does not significantly change the chances of patients stopping insulin, challenging previous assumptions about their role in insulin withdrawal. A new analysis of veterans with…
Research reveals that combining GLP-1 receptor agonists with basal insulin does not significantly increase the likelihood of insulin discontinuation in adults with type 2 diabetes, challenging assumptions about their role in insulin dependency reduction. Adding a GLP-1 drug to basal…
A new meta-analysis of 23 trials reveals that reducing carbohydrate intake to below 45% of daily energy may yield small weight loss and risk marker improvements for adults with overweight or obesity, but the benefits are limited and vary with…
